The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
An introduction to the free radical hypothesis in Parkinson's disease
Abstract
Iron-induced oxidant stress has been implicated in the pathogenesis of Parkinson's disease. An increasing body of evidence now indicates that in Parkinson's disease the environment within the substantia nigra is conducive to the formation of cytotoxic free radicals and cell degeneration. Dopamine neurons may be particularly vulnerable because of the oxidative metabolism of dopamine and the potential of neuromelanin to promote the site-specific accumulation and reduction of iron. This hypothesis has attracted considerable attention because it opens the way for employing antioxidant strategies as possible neuroprotective treatment for Parkinson's disease. Although the concept is appealing, free radicals have not yet been proven to play a role in Parkinson's disease, and many important issues remain to be resolved before the oxidative hypothesis can ultimately be confirmed or refuted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation is in agreement with a similar analysis that was performed on autopsy specimens ([51](#R51)).”
From Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease (1997) · cites this paper as [51]
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Mitochondrial DNA and human evolution
Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100
Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts
Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Oxygen radicals and human disease
CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 14
- Halliwell, 1985, TINS, 8, 22
- Cohen, 1990, Neural Transm, 32, 229
- Olanow, 1990, Neurology, 40, 32
- Halliwell, 1988, ISI Atlas Sci Biochem, 1, 48
- Potts, 1976, Exp Eye Res, 48, 221
- Sarna, 1976, Science, 1132, 192
- Brain iron: MRI studies in Parkinson's syndrome. In: eds. Florham Park, New Jersey: MacMillan Healthcare, 1987: 135-143
- Sengstock, 1991, Movement Dis, 6, 272
- Olanow, 1991, Neurology, 42, 13
- Riederer, 1989, J Neurochem, 52, 515, 10.1111/j.1471-4159.1989.tb09150.x · DOI · Paper page
- Good, 1992, J Neuropathol Exp Neurol, 51, 327
- et al. Vitamin E levels in brain are not altered in Parkinson's disease. Ann Neurol 1992 (in press)
- et al. Brain skeletal muscle and platelet mitochondrial function in Parkinson's disease. Brain 1992 (in press)
- Spina, 1988, J Pharmacol Exp Ther, 247, 502
Cited by
Sorted by citations
Items 101–200 of 381
The Role of Reactive Oxygen Species (ROS) in Persistent Pain
Chung, J. M. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.3 · Cited by 83
Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate
Maâroufi, K., Ammari, M., Jeljeli, M., Roy, V., Sakly, M., & Abdelmelek, H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.10.019 · Cited by 83
Alteration of free radical metabolism in the brain of mice infected with scrapie agent
Lee, D. W., Sohn, H. O., Lim, H. B., Lee, Y. G., Kim, Y. S., Carp, R. I., & Wı́sniewski, H. M. (1999) · Free Radical Research · doi:10.1080/10715769900300541 · Cited by 82
Mazlan, M., Then, S., Top, G. M., & Ngah, W. Z. W. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.006 · Cited by 80
Oxidative stress and Parkinson's disease
Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 79
Age-related neurodegeneration and oxidative stress: putative nutritional intervention.
Joseph, J., Denisova, N., Fisher, D., Shukitt-Hale, B., Bickford, P., Prior, R., & Cao, G. (1998) · Neurologic clinics · doi:10.1016/s0733-8619(05)70092-x · Cited by 85
Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan, V. (2002) · PubMed · Cited by 78
Studies on genomic DNA topology and stability in brain regions of Parkinson’s disease
Hegde, M. L., Gupta, V. B., Anitha, M., Harikrishna, T., Shankar, S. K., Muthane, U. B., Rao, K. S. J., & Rao, K. S. J. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.018 · Cited by 77
Camarero, J., Sánchez, V., O’Shea, E., Green, A. R., & Colado, M. I. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00879.x · Cited by 77
Ahlbom, E., Grandison, L., Bonfoco, E., Zhivotovsky, B., & Ceccatelli, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00529.x · Cited by 76
Jeong, K., Shin, Y. C., Park, S., Park, J.-S., Kim, N., Um, J., Go, H.-Y., Sun, S., Lee, S., Park, W., et al. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-14 · Cited by 75
Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2
Offen, D., Ziv, I., Panet, H., Wasserman, L., Stein, R., Melamed, E., & Barzilai, A. (1997) · Cellular and Molecular Neurobiology · doi:10.1023/a:1026390201168 · Cited by 75
The effects of aging and oxidative stress on psychomotor and cognitive behavior
Shukitt‐Hale, B. (1999) · AGE · doi:10.1007/s11357-999-0002-7 · Cited by 74
Spada, P. D. S., Dani, C., Bortolini, G. V., Funchal, C., Henriques, J. A. P., & Salvador, M. M. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0236 · Cited by 73
Neuroprotective effects of D3 dopamine receptor agonists
Carvey, P. M., McGuire, S. O., & Ling, Z. D. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00061-4 · Cited by 73
Melatonin suppresses iron-induced neurodegeneration in rat brain
Lin, A. M.-Y., & Ho, L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00169-6 · Cited by 72
Tsuda, T., Munthasser, S., Fraser, P. E., Percy, M. E., Rainero, I., Vaula, G., Pinessi, L., Bergamini, L., Vignocchi, G., McLachlan, D. R. C., et al. (1994) · Neuron · doi:10.1016/0896-6273(94)90039-6 · Cited by 71
Yeo, J. E., Kim, J. H., & Kang, S. K. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000113764 · Cited by 70
Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
Trépanier, G., Furling, D., Puymirat, J., & Mirault, M.-É. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00222-9 · Cited by 70
Joseph, J. A., Villalobos‐Molina, R., Denisova, N., Erat, S., Cutler, R., & Strain, J. G. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02225-2 · Cited by 70
Mitochondria in activated microglia in vitro
Banati, R. B., Egensperger, R., Maaßen, A., Hager, G., Kreutzberg, G. W., Manuel, B. R., & Graeber (2004) · Journal of Neurocytology · doi:10.1007/s11068-004-0515-7 · Cited by 74
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722516.x · Cited by 69
Neuroprotective and Cognition-Enhancing Effects of Compound K Isolated from Red Ginseng
Seo, J. Y., Ju, S. H., Oh, J., Lee, S. K., & Kim, J. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05789 · Cited by 66
Ling, Z. D., Robie, H. C., Tong, C. W., & Carvey, P. M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38124-8 · Cited by 66
Levodopa-Induced Neurotoxicity
Fahn, S. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00004 · Cited by 66
The nosology of Hallervorden-Spatz disease
HALLIDAY, W. C. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00212-k · Cited by 64
Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices
Feeney, C. J., Frantseva, M. V., Carlen, P. L., Pennefather, P., Shulyakova, N., Shniffer, C., & Mills, L. R. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.049 · Cited by 62
Adult Chédiak-Higashi syndrome presenting as parkinsonism and dementia
Uyama, E., Hirano, T., Ito, K., Nakashima, H., Sugimoto, M., Naito, M., Uchino, M., & Ando, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01657.x · Cited by 63
A new look at levodopa based on the ELLDOPA study
Fahn, S. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_63 · Cited by 63
Joseph, J. A., Denisova, N., FISHER, D., Shukitt‐Hale, B., Bickford, P. C., Prior, R. L., & Cao, G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09908.x · Cited by 62
Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine
Vu, T. Q., Ling, Z. D., Y., S., Robie, H. C., Tong, C. W., Chen, E.-Y., Lipton, J. W., & Carvey, P. M. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050014 · Cited by 61
Mawatari, K., Yasui, Y., Sugitani, K., Takadera, T., & Kato, S. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00025-5 · Cited by 60
Wermuth, L., & The Danish Pramipexole Study Group (1998) · European Journal of Neurology · doi:10.1046/j.1468-1331.1998.530235.x · Cited by 59
The CERAD experience, part VIII
Davis, P. C., Gearing, M., Gray, L., Mirra, S. S., Morris, J. C., Edland, S. D., Lin, T., & Heyman, A. (1995) · Neurology · doi:10.1212/wnl.45.1.178 · Cited by 59
Neuroprotective and Antioxidative Effect of Cactus Polysaccharides In Vivo and In Vitro
Huang, X., Li, Q., Li, H., & Guo, L. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9417-z · Cited by 58
Brain Iron Homeostasis and Mental Disorders
Wu, Q., Ren, Q., Meng, J., Gao, W., & Chang, Y. (2023) · Antioxidants · doi:10.3390/antiox12111997 · Cited by 62
Differential regulation of the mitochondrial and death receptor pathways in neural stem cells
Tamm, C., Robertson, J. D., Sleeper, E., Enoksson, M., Emgård, M., Orrenius, S., & Ceccatelli, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03391.x · Cited by 55
Yoshida, E., Mokuno, K., Aoki, S., Takahashi, A., Riku, S., Murayama, T., Yanagi, T., & Kato, K. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90006-x · Cited by 55
Fruit extracts antagonize Aβ- or DA-induced deficits in Ca2+ flux in M1-transfected COS-7 cells
Joseph, J., Fisher, D., & Carey, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6408 · Cited by 51
Attenuation of Oxidative Neuronal Necrosis by a Dopamine D1 Agonist in Mouse Cortical Cell Cultures
Noh, J. S., & Gwag, B. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6569 · Cited by 53
Aging and oxygen toxicity: Relation to changes in melatonin
Reiter, R. J. (1997) · AGE · doi:10.1007/s11357-997-0020-2 · Cited by 52
Camp, D. M., Loeffler, D. A., & LeWitt, P. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741229.x · Cited by 52
Olanow, C. W., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50006-0 · Cited by 50
Self-citationMitochondrial Genome Analysis of Primary Open Angle Glaucoma Patients
Banerjee, D., Banerjee, A., Mookherjee, S., Vishal, M., Mukhopadhyay, A., Sen, A., Basu, A., & Ray, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070760 · Cited by 48
Valvassori, S. S., Petronilho, F. C., Réus, G. Z., Steckert, A. V., Oliveira, V. B. M., Boeck, C. R., Kapczinski, F. P., Dal‐Pizzol, F., & Quevedo, J. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.02.012 · Cited by 49
Nanotherapeutics for Alzheimer’s disease (AD): Past, present and future
Fazil, M., Shadab, Baboota, S., Sahni, J. K., & Ali, J. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.607499 · Cited by 47
The effects of dietary antioxidants on psychomotor performance in aged mice
Shukitt‐Hale, B., Smith, D. E., Meydani, M., & Joseph, J. A. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00039-x · Cited by 47
Spatial Learning and Memory Deficits Induced by Dopamine Administration with Decreased Glutathione
Shukitt‐Hale, B., Erat, S., & Joseph, J. A. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00399-7 · Cited by 46
Zhao, W., Latinwo, L. M., Liu, X., Lee, E.-S., Lamango, N. S., & Charlton, C. G. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7726 · Cited by 46
DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease
Hegde, M. L. (2009) · Frontiers in bioscience · doi:10.2741/3628 · Cited by 46
Liu, X.-H., Kato, H., Chen, T., Kato, K., & Itoyama, Y. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00239-k · Cited by 46
Chakraborti, A., Gulati, K., & Ray, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.027 · Cited by 45
Dopamine neurotoxicity: age-dependent behavioral and histological effects
Cantuti‐Castelvetri, I., Shukitt‐Hale, B., & Joseph, J. A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00186-0 · Cited by 45
Bergeron, C., Petrunka, C. N., & Weyer, L. (1996) · PubMed Central · Cited by 45
Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting Model
Björklund, L., Spenger, C., & Strömberg, I. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6655 · Cited by 45
Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures
Di Monte, D. A., Schipper, H. M., Hetts, S., & Langston, J. W. (1995) · Glia · doi:10.1002/glia.440150213 · Cited by 43
Comparison between multiple sclerosis in India and the United States
Bansil, S., Singhal, B. S., Gk, A., Ladiwala, U., Behari, M., Friede, R. L., & Cook, S. D. (1996) · Neurology · doi:10.1212/wnl.46.2.385 · Cited by 43
Crema, L. M., Schlabitz, M. K., Tagliari, B., da Cunha, A. A., Simão, F., Krolow, R., Pettenuzzo, L. F., Salbego, C. G., Vendite, D., Wyse, Â. T. D. S., et al. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0245-9 · Cited by 44
Motor Neuron Disease With Parkinsonism
Qureshi, A. I., Wilmot, G. R., Dihenia, B., Schneider, J. A., & Krendel, D. A. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550100061015 · Cited by 43
Castilho, R. F., Hansson, O., & Brundin, P. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)27011-8 · Cited by 44
Beneficial effects of berry fruit polyphenols on neuronal and behavioral aging
Lau, F. C., Shukitt‐Hale, B., & Joseph, J. A. (2006) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.2671 · Cited by 42
Ge, Y., Wu, F., Sun, X., Xiang, Z., Yang, L., Huang, S., Lu, Z., Sun, Y., & Yu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097436 · Cited by 42
Metal Chelators Coupled with Nanoparticles as Potential Therapeutic Agents for Alzheimer's Disease
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.005 · Cited by 43
A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease
Olanow, C. W. (1993) · Movement Disorders · doi:10.1002/mds.870080503 · Cited by 42
Self-citationFetal tissue transplanation in Parkinson’s disease
Tabbal, S. D., Fahn, S., & Frucht, S. J. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199808000-00010 · Cited by 41
Energy drinks and their component modulate attention, memory, and antioxidant defences in rats
Valle, M. T. C., Pereira, N. D. S. C., Lampert, C., Arcego, D. M., Toniazzo, A. P., Limberger, R. P., Dallegrave, E., Dalmaz, C., Arbo, M. D., & Leal, M. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1522-z · Cited by 40
Bonda, D., Liu, G., Men, P., Perry, G. L., Smith, M. A., & Zhu, X. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712799960709 · Cited by 39
Noschang, C. G., Krolow, R., Pettenuzzo, L. F., Ávila, M. C., Fachin, A., Arcego, D. M., Toigo, E. V. P., Crema, L. M., Diehl, L. A., Vendite, D., et al. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9945-4 · Cited by 39
Azman, K. F., Zakaria, R., Othman, Z., & Aziz, C. B. A. (2018) · Journal of Taibah University for Science · doi:10.1080/16583655.2018.1465275 · Cited by 39
Levant, B., Ling, Z. D., & Carvey, P. M. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00006 · Cited by 39
Rowland, L. P., Sherman, W. L., Hays, A. P., Lange, D. J., Latov, N., Trojaborg, W., & Younger, D. S. (1995) · Neurology · doi:10.1212/wnl.45.4.827 · Cited by 39
Qualitative versus quantitative caloric intake: are they equivalent paths to successful aging?
Casadesús, G., Shukitt‐Hale, B., & JOSEPH, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00079-9 · Cited by 40
Martín, M. A., Molina, J. A., Jiménez-Jiménez, F. J., Benito‐León, J., Pareja, M. O., Campos, Y., Arenas, J., & del Movimiento, T. G. C. D. T. (1996) · Neurology · doi:10.1212/wnl.46.5.1343 · Cited by 39
Drukarch, B., Jongenelen, C. A. M., Schepens, E., Langeveld, C. H., & Stoof, J. C. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06038.1996 · Cited by 39
Iron chelation beyond transfusion iron overload
Pietrangelo, A. (2007) · American Journal of Hematology · doi:10.1002/ajh.21101 · Cited by 38
Contextual Fear Conditioning in Maternal Separated Rats: The Amygdala as a Site for Alterations
Diehl, L. A., Pereira, N. D. S. C., Laureano, D. P., Benitz, A. N. D., Noschang, C. G., Ferreira, A. G. K., Scherer, E. B. D. S., Machado, F. R., Henriques, T. P., Wyse, Â. T. D. S., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1230-x · Cited by 43
Wu, Y., Bi, L., Bi, W., Zeng, L., Zhao, M., Wang, C., Ju, J., & Peng, S. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.04.016 · Cited by 38
Chen, G., Wang, Y., Hao, X., Mu, S., & Sun, Q. (2011) · Chemistry Central Journal · doi:10.1186/1752-153x-5-37 · Cited by 38
Medical treatment of Parkinson’s disease
Fahn, S. (1998) · Journal of Neurology · doi:10.1007/pl00007742 · Cited by 38
Hristova, A. H., & Koller, W. C. (2000) · Drugs & Aging · doi:10.2165/00002512-200017030-00002 · Cited by 38
Absence of Mutations in Superoxide Dismutase and Catalase Genes in Patients With Parkinson's Disease
Parboosingh, J. S., Rousseau, M., Rogan, F., Amit, Z., Chertkow, H. M., Johnson, W. G., Manganaro, F., Schipper, H., Curran, T. J., Stoessl, A. J., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360038013 · Cited by 38
Wang, F. T., Chen, L., Tian, C., Yan, M., Wang, Z., Zhang, R. Q., Jin, M., Zhang, P., & Ding, D. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21910 · Cited by 37
Hydrogen Peroxide and Amyotrophic Lateral Sclerosis: From Biochemistry to Pathophysiology
Sanghai, N., & Tranmer, G. K. (2021) · Antioxidants · doi:10.3390/antiox11010052 · Cited by 37
Oxidative stress and age-related neuronal deficits
Joseph, J. A., Denisova, N., Villalobos‐Molina, R., Erat, S., & Strain, J. G. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815202 · Cited by 37
Ceccon, M., Giusti, P., Facci, L., Borin, G., Imbesi, M., Floreani, M., & Skaper, S. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02074-6 · Cited by 36
Polymorphisms of the Parkin Gene in Sporadic Parkinson’s Disease among Chinese in Taiwan
Hu, C., Sung, S., Liu, H., Lee, C.-C., Tsai, C., & Chang, J. (2000) · European Neurology · doi:10.1159/000008203 · Cited by 36
Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews
Blumen, S. C., Sadeh, M., Korczyn, A. D., Rouche, A., Nisipeanu, P., Asherov, A., & Tomé, F. M. S. (1996) · Neurology · doi:10.1212/wnl.46.5.1324 · Cited by 36
Hao, R., Norgren, R. B., Lau, Y., & Pfeiffer, R. F. (1995) · Neurology · doi:10.1212/wnl.45.1.138 · Cited by 35
Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper
Snyder, R. D., & Friedman, M. B. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00117-1 · Cited by 34
Cellular Models to Study Dopaminergic Injury Responses
Collier, T. J., Steece‐Collier, K., McGuire, S. O., & Sortwell, C. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07472.x · Cited by 34
Sofic, E., Denisova, N., Youdim, K. A., Vatrenjak-Velagic, V., Filippo, C. D., Mehmedagić, A., Causevic, A., Cao, G., Joseph, J. A., & Prior, R. L. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170055 · Cited by 34
Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
Jenner, P. G., & Olanow, C. W. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50004-7 · Cited by 34
Self-citationMarcolin, M. L., Benitz, A. N. D., Arcego, D. M., Noschang, C. G., Krolow, R., & Dalmaz, C. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.025 · Cited by 33
Deeb, S. A., Moutaery, K. A., Khan, H. A., & Tariq, M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00075-6 · Cited by 33
Park, J., Kim, B., Park, S., Jin, J., Jeon, Y., Wen, G. Y., Shin, H., Carp, R. I., & Kim, Y. (2010) · Hippocampus · doi:10.1002/hipo.20753 · Cited by 33
Shetty, P., Atallah, M. T., & Shetty, K. (2003) · Process Biochemistry · doi:10.1016/s0032-9592(02)00257-1 · Cited by 33
Pietraszek, M., Michaluk, J., Romańska, I., Wąsik, A., Gołembiowska, K., & Antkiewicz‐Michaluk, L. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9097-y · Cited by 33
Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain
Englander, E. W., Greeley, G. H., Wang, G., Perez-Polo, J. R., & Lee, H.-M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991015)58:2 · Cited by 51
The Effects of Hydroxyl Radical Attack on Dopa, Dopamine, 6‐Hydroxydopa, and 6‐Hydroxydopamine
Nappi, A. J., Vass, E., Prota, G., & Memoli, S. (1995) · Pigment Cell Research · doi:10.1111/j.1600-0749.1995.tb00676.x · Cited by 33
Therapeutic Potential of AMPA Receptor Ligands in Neurological Disorders
Lees, G. J. (1996) · CNS Drugs · doi:10.2165/00023210-199605010-00005 · Cited by 33
Metadata
- Authors
- Olanow, C. W.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Olanow, C. W.
- ORCID
- Olanow, C. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1992
- Volume
- 32
- Issue
- S1
- Pages
- S2-S9
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2156259977
- Cited by
- 382
- References
- 68
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 2 · 2014: 6 · 2013: 5 · 2012: 13
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, oxidative stress, iron accumulation, substantia nigra, dopaminergic neurons, neuromelanin, dopamine oxidation, neuroprotection, antioxidants, neurodegeneration
- MeSH terms
- Animals, Free Radicals, Humans, Iron, Parkinson Disease, Substantia Nigra, Lipid Peroxidation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review